Literature DB >> 26926973

Hyperthyroidism: Diagnosis and Treatment.

Igor Kravets1.   

Abstract

Hyperthyroidism is an excessive concentration of thyroid hormones in tissues caused by increased synthesis of thyroid hormones, excessive release of preformed thyroid hormones, or an endogenous or exogenous extrathyroidal source. The most common causes of an excessive production of thyroid hormones are Graves disease, toxic multinodular goiter, and toxic adenoma. The most common cause of an excessive passive release of thyroid hormones is painless (silent) thyroiditis, although its clinical presentation is the same as with other causes. Hyperthyroidism caused by overproduction of thyroid hormones can be treated with antithyroid medications (methimazole and propylthiouracil), radioactive iodine ablation of the thyroid gland, or surgical thyroidectomy. Radioactive iodine ablation is the most widely used treatment in the United States. The choice of treatment depends on the underlying diagnosis, the presence of contraindications to a particular treatment modality, the severity of hyperthyroidism, and the patient's preference.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26926973

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  16 in total

1.  Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care.

Authors:  Richard Birtwhistle; Kate Morissette; James A Dickinson; Donna L Reynolds; Marc T Avey; Francesca Reyes Domingo; Rachel Rodin; Brett D Thombs
Journal:  CMAJ       Date:  2019-11-18       Impact factor: 8.262

2.  Proteomics Profiling of the Urine of Patients with Hyperthyroidism after Anti-Thyroid Treatment.

Authors:  Hicham Benabdelkamel; Afshan Masood; Aishah A Ekhzaimy; Assim A Alfadda
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

3.  Potassium Supplementation to Prevent Severe Hypokalemia and Paralysis after High-Dose Methylprednisolone for Ophthalmopathy in Uncontrolled Graves Disease: A Case Report.

Authors:  Alix-Anne Gendron; Antoine Marquis; Carolanne Mongeon; Andreea Statie; Audrey Bouchard; Michael Khazaka
Journal:  Can J Hosp Pharm       Date:  2022-07-04

4.  Relationship between body mass index and external exposure in hyperthyroid patients treated with iodine-131.

Authors:  Ghazal Yazdanpanah; Mohammad Nematdar; Hoda Talebian; Ali Shabestani Monfared
Journal:  Am J Nucl Med Mol Imaging       Date:  2022-06-15

Review 5.  Insight Into Mouse Models of Hyperthyroidism.

Authors:  Mengyu Zhang; Wen Jiang; Ganghua Lu; Ru Wang; Zhongwei Lv; Dan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-22       Impact factor: 6.055

6.  Graves Disease in Central Ghana: Clinical Characteristics and Associated Factors.

Authors:  Osei Sarfo-Kantanka; Fred Stephen Sarfo; Eunice Oparebea Ansah; Ishmael Kyei
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2018-03-21

7.  Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review.

Authors:  Francesca Reyes Domingo; Marc T Avey; Marion Doull
Journal:  Syst Rev       Date:  2019-11-18

8.  Changes in bone mineral density after parathyroidectomy in patients with moderate to severe primary hyperparathyroidism.

Authors:  Shuai Lu; Maoqi Gong; Yejun Zha; Aimin Cui; Chen Chen; Hao Yang; Weitong Sun; Kehan Hua; Wei Tian; Xieyuan Jiang
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

9.  De novo coronary artery disease in graves' disease. coincidence?

Authors:  Dariush Shahsavari; Bryan Zoll
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-10-15

10.  Reversible Affective Symptoms and Attention Executive Control Network Impairment Following Thyroid Function Normalization in Hyperthyroidism.

Authors:  Lili Yuan; Yuanxiang Zhang; Di Luan; Xiangjun Xu; Qian Yang; Shoucai Zhao; Zhiming Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2019-11-26       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.